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Sllmmary 
Major histocompatibility complex (MHC) class I molecules generally present peptides derived 
from cytoplasmic proteins,  but recent reports have suggested  that macrophages  (MO) may be 
uniquely able to present exogenous antigens via these molecules, and that particle-assodated antigens 
show a marked increase in the efficiency of such presentation.  We confirm here that particle 
uptake by MO permits exogenous ovaalbumin  (OVA) to gain access to the endogenous class 
I processing pathway, an event that occurs rarely, if at all, in the absence of phagocytic stimuli. 
Presentation  of soluble protein antigens by MHC class I molecules, however, is not limited to 
MO, nor is direct coupling of antigen to the particle required. A variety of unconjugated particles 
promoted presentation  of simultaneously  offered soluble OVA to Kb-restricted T cells by both 
MO and non-MO antigen-presenting cells (APC), provided  the latter could phagocytose  the 
particles. Enhancement of presentation  by phagocytic stimuli could not be explained by greater 
delivery of soluble antigen to endosomal compartments because such stimuli did not increase 
soluble tracer accumulation, nor did they improve presentation of OVA to an MHC class II-restricted 
T  cell hybridoma. OVA presentation  induced by cophagocytosis  of particles and free antigen 
was nevertheless very inefficient in comparison to presentation of OVA peptide, and even modest 
responses required high concentrations of protein and particles.  Furthermore, only a fraction 
of APC exposed to OVA and particles were lysed by anti-OVA cytotoxic T lymphocytes, despite 
virtually all cells showing OVA accumulation, particle  uptake,  and K b expression.  Titration 
experiments  were most consistent with a model in which, by disrupting membrane integrity, 
phagocytic overload ("indigestion") allows escape of OVA into the cytosol of some APC, rather 
than with a model in which phagocytosis activates a novel antigen processing pathway that has 
evolved to permit class I loading of exogenous antigen. These data suggest caution in the development 
of vaccine strategies based on use of particle conjugates for elicitation of CD8 + T cell immunity, 
but, at the same time, may be relevant to understanding class I-restricted responses to some 
intracellular  pathogens normally resident  in membrane-bound vesicles. 
C 
lass I proteins  of the MHC display at the cell surface 
a sample of peptides derived from cellular proteins,  al- 
lowing T lymphocytes to respond to intracellular pathogens 
or mutated cellular antigens that would otherwise remain 
undetectable.  Because MHC class I molecules are generally 
involved in presenting peptides to CTL, whose effector func- 
tion is best restricted to actively infected cells, it makes bio- 
logical sense that these MHC molecules should be limited 
in their ability to acquire peptides derived from proteins in 
the extracellular milieu (exogenous antigens). This would help 
prevent healthy cells from becoming sensitized for CTL lysis 
by foreign, noninfectious proteins released from neighboring 
infected or transformed cells. This notion is supported by 
numerous experimental  observations  that soluble intact ex- 
ogenous proteins can be presented by class I only when ad- 
ministered in fusogenic form or deliberately introduced into 
the cytosol by in vitro manipulations (1). If exogenous an- 
tigens were completely excluded from the class I pathway, 
however,  it  is  unclear how  immune responses  could be 
mounted against  intracellular  parasites residing  in the en- 
dosomal compartment of MHC class II-negative cells or 
against viruses that do not infect professional class II-posi- 
tive APC. Moreover, several instances of MHC class I pre- 
sentation  of peptides  from putatively nonfusogenic exoge- 
nous antigens have been reported (2-8) and class I-restricted 
CTL responses against endosomal parasites are essential in 
controlling many parasitic infections (9, 10). Together, these 
observations suggest the existence  of mechanisms for delivering 
841  The Journal of Experimental Medicine ￿9 Volume 182  September 1995  841-851 peptides from exogenous antigens to class I molecules, and 
they have led to the hypothesis that there exist APC that 
are specialized  to do so (11). 
One such APC has been tentatively identified as a macro- 
phage (MO) 1 (8, 12-14).  Recent studies have suggested that 
exogenous antigens in particulate form markedly increase the 
efficiency of dass I presentation by MO, but it is not clear 
whether phagocytosis merely augments antigen uptake or 
has a qualitative effect on antigen handling (15-18). Further- 
more, two different pathways have been described as con- 
tributing to exogenous antigen presentation by MHC class 
I molecules, one involving peptide regurgitation from phago- 
somes and binding to cell surface class I (15, 17), and another 
involving antigen transfer into the cytosol and processing via 
the conventional MHC class I pathway (16, 18). The latter 
studies suggested that a novel mechanism might exist for trans- 
port of proteins or their partial degradation products from 
endosomes/phagosomes to the cytosol. In this report, we pro- 
vide evidence that phagocytosis can induce a qualitative change 
in antigen handling, not only by MO, but also by a variety 
of phagocyticaUy competent, non-MO APC that is inde- 
pendent of a quantitative effect on antigen delivery and that 
permits class I presentation of soluble exogenous antigens by 
a fraction of APC. The change in antigen handling induced 
by phagocytosis appears to result from a loss of phagosomal 
membrane integrity and escape of antigen into the cytosol, 
however, rather than upregulation of a novel specific trans- 
port system designed for delivery of exogenous antigens into 
the endogenous antigen processing pathway. These observa- 
tions are discussed  in the context of immune responses  to 
replicating endosomal parasites and of vaccine development. 
Materials and Methods 
Mice.  Female  C57BL/6  (B6) and B10.A mice were obtained 
from the National Cancer Institute (National Institutes of Health 
[NIH], Bethesda, MD), and they were used between 6 and 18 wk 
of age. 
Media.  RPMI 1640 or DMEM medium (BioFluids, Rockville, 
MD) was supplemented  with glutamine, nonessential  amino acids, 
Hepes, sodium pyruvate, antibiotics, 10% FCS (all from Biofluids), 
and 2-ME. RPMI 1640 complete medium was used for all func- 
tional assays  and for culturing all cell types, except BO-97.11 and 
E3 K  b, which were cultured in complete DMEM medium. 
Reagents.  OVA grades V, VI, or VII was purchased from Sigma 
Chemical  Co. (St. Louis,  MO). It was dissolved  in complete  medium 
at a stock concentration of 40 mg/ml and prepared fresh periodi- 
cally. Different batches of OVA gave varying degrees of extracel- 
lular generation of  class I peptides, independently of grade (see Re- 
sults). BSA grade VIII was purchased from Sigma. OVA peptides 
257-264 (SIINFEKL) and 323-339 (ISQAVHAAHAEINEAGR) 
were synthesized by Dr. J. Coligan (National Institute of Allergy 
and Infectious Diseases, NIH, Bethesda, MD). Brefeldin A was 
purchased from Epicentre Technologies  (Madison, WI). FITC-OVA 
1 Abbreviations used in thispaper: BFA, brefeldin  A; CCD, cytochalasin  D; 
CHX, cycloheximide;  EC, epidermal  cells; EK, endoplasmic  reticulnm; 
MO, macrophages;  PEC, peritoneal  exudate  cells; TAP, transporter asso- 
ciated with antigen processing; Thio-, thioglycollate-elicited, 
was purchased from Molecular  Probes, Inc. (Eugene, OR). All other 
reagents were purchased from Sigma. 
OVA and BSA beads or mock-conjugated  beads were Biomag  TM 
amino-terminated  magnetic particles (PerSeptive  Diagnostics,  Cam- 
bridge, MA) of 1-/zm nominal diameter (range =  1-10 #m) cou- 
pled covalently  or mock-coupled to protein per the manufacturer's 
recommendations. Briefly, the beads were washed three times by 
magnetic separation in 10 mM pyridine, pH 6, activated with 5% 
glutaraldehyde,  and washed again. BSA, OVA, or no protein were 
added to ~20% of the bead weight in pyridine buffer and the sus- 
pension was rotated overnight at room temperature. Any remaining 
activated sites were quenched with 1 M glycine for 1 h, and the 
conjugated beads were washed three times in PBS/1% FCS fol- 
lowed by a wash in complete  medium. The amount of protein bound 
to the particles was estimated from the difference  in protein con- 
tent of the supernatant before and after coupling, measured using 
a colorimetric  protein assay  (Bio Rad Laboratories, Richmond, CA). 
Coupling efhciency  ranged from 2.3 to 7.2 mg protein/ml (0.1-0.3 
pg protein per bead). Fluoresbrite  TM carboxylated latex beads of 
1-, 1.5-, and 2-/~m diameter and Polybeads  TM latex beads of 1.5- 
/~m diameter were purchased from Polysciences  (Warrington, PA). 
Zymosan A was purchased from Sigma and prepared as described 
(19). Fixed Staphylococcus  aureus  (Pansorbin  TM) was from Calbio- 
chem (La  Jolla, CA). All particles  were washed  in complete  medium, 
and stocks were prepared in the same medium and kept at 4~ 
APC.  Thioglycollate-induced inflammatory MO (thio-MO) 
were obtained by adherence to tissue culture plastic of peritoneal 
exudate cells (PEC) obtained through lavage  of the peritoneal  cavity 
of mice injected intraperitoneally 4-5  d previously with 1 ml 
thioglycollate  broth (NIH Media Unit). In some experiments, un- 
fractionated PEC were used; there was no difference in antigen 
presentation between adherent and unfractionated PEC (Reis e 
Sousa, C.,  and R. N. Germain, unpublished observations). 
Epidermal cells (EC) were prepared as described (19) and were 
depleted of Langerhans cells by treatment  with mAbs M5/114 
(anti-I-A  b [20]) and NLDC-145 (21) followed by immunomag- 
netic separation with sheep anti-rat Dynabeads  TM (Dynal, Oslo, 
Norway) per the manufacturer's instructions. Depletion was as- 
sessed by loss of presentation of OVA or OVA 323-339 peptide 
to the BO-97.11 T cell hybridoma (not  shown). 
1-3 (K  b) is an L cell line transfected with K  b (22). EE2H3 is 
a cell line derived from H-2  k mouse embryos that was transfected 
with K  b to obtain E3 K  b (23). E3 K  b cells were pretreated with 
2,000 U/ml IFN-cr  to upregulate class I expression before use 
in antigen presentation assays (24). 
T  Cell Hybridomas and Lines.  B3Z,  a CD8 + T cell hybridoma 
specific for the OVA 257-264 peptide (SIINFEKL) in the context 
of K  b (25), was a generous gift from Dr. N. Shastri (University 
of California, Berkeley, CA). BO-97.11, a CD4 + T cell hybridoma 
that responds to the peptide OVA 323-339 presented by I-A  b (26), 
was a kind gift from Dr. P. Marrack (National Jewish Center for 
Respiratory Medicine, Denver, CO). 
CTL lines specific for SIINFEKL +  K  b were generated from 
B6 mice immunized with a vaccinia  construct expressing the SIIN- 
FEKL epitope (27). Briefly,  spleen  cells from immunized mice (kind 
gift from Dr. J. Bennink, NIAID, NIH, Bethesda, ME)) were re- 
stimulated in vitro with SIINFEKL peptide and polyclonal CTL 
effectors were generated. Lines  were established  from these effectors 
by culturing with irradiated (2,000 rad) B6 spleen cells pulsed with 
SIINFEKL in 24-well plates (Costar Corp., Cambridge, MA) in 
medium containing  7.5%  T-Stim  TM  (Collaborative Biomedical 
Products, Bedford, MA). Cultures were restimulated every  2-3 wk 
or were expanded for CTL assays  by transferring cells to 25-cm  2 
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stimulators and culturing for 7 d, increasing the concentration  of 
T-Stim  TM to 15% on day 3. 
Antigen Presentation Assays.  APC.  (generally 5-10  x  104) were 
cultured in 96-wall flat-bottom phtes (Costar) in 200 #1 complete 
RPMI 1640 medium with the concentrations of antigen and parti- 
cles indicated in each experimental protocol. In some experiments, 
5-10  x  104 T hybridoma cells were cocultured with antigen and 
APC, whereas in others, T cells were added to antigen-pulsed, fixed, 
or live APCs as indicated for each figure. Indomethacin  (0.25-2 
#M) was sometimes included in assays with live APCs. Adherent 
MO were fixed in 1% paraformaldehyde in PBS for 10 min at room 
temperature followed by quenching with 0.1 M glycine in PBS for 
a similar length of time and washing thoroughly in medium be- 
fore culture  with T hybridoma  cells. 
IL-2 production by T cell hybrids was measured in most experi- 
ments as the ability of serial dilutions of assay supernatant to stimu- 
late  incorporation  of [3H]thymidine  by the  indicator  cell line 
CTLL-2. In most figures, data are expressed as mean cpm of CTLb2 
cultured in a 1:4 dilution of supematants  from triplicate cultures; 
all error bars represent one SD from the mean. Where possible 
(see Fig. 5 B), IL-2 units  were calculated from supernatant  dilu- 
tions, as described (28). In a few experiments (see Fig. 7 B), Ib2 
concentrations  were determined by ELISA using antibodies pur- 
chased from PharMingen  (San Diego, CA) per the manufacturer's 
instructions  with minor modifications. Data from those experi- 
ments are expressed as IL-2 U/m1, calculated by comparison with 
an Ib2 standard curve. The sensitivity of the Ib2 ELISA was com- 
parable to that of the CTLL-2 assay (Reis e Sousa, C., and K. N. 
Germain,  unpublished  results). 
Since B3Z contains the lacZ reporter gene under the control of 
the human NF-AT element (25), activation of this hybridoma was 
assayed in some experiments through measurement of B-galactosi- 
dase activity induced in activated cells using o-nitrophenyl-/3-D- 
galactopyranoside, exactly as described (29). 
CTL Assays.  Target  cells that had been prepulsed with antigen 
were labeled with "~100 #Ci SlCr sodium chromate (Amersham 
Corp., Arlington Heights, IL) in 50% FCS for 1 h at 37~  washed 
in PBS, and cultured in medium for 1 h before washing again. 2 
x  104 targets were added to a titration  of CTL effectors in 96- 
well round-bottom plates in a final volume of 200 #1 complete 
medium, centrifuged to promote cell contact, and incubated at 37~ 
for 4 h. Supernatants were harvested manually (100 #1) or mechan- 
ically using a supernatant collection system (Skatron Instruments, 
Sterling, VA). Radioactivity released into the supernatant was mea- 
sured in a gamma counter (Beckman Instruments,  Irvine, CA), 
and percent specific release was calculated from the mean of tripli- 
cate cultures  according to the following formula: 
percent  specific release = 
100  x  (experimental  release  -  spontaneous  release) 
(maximal release (1% NP-40)  -  spontaneous  release). 
Flow Cytornetry.  Cells  were  analyzed  using  a  FACScan  TM 
cytometer and Lysys  TM software (Becton Dickinson & Co., Moun- 
tain View, CA). Staining for K  b was performed using mAb AF6- 
88.5 directly  conjugated  to FITC or FITC-mouse IgGa as an 
isotype-matched negative control (both from PharMingen).  Flow 
cytometric phagocytosis and endocytosis assays  were performed es- 
sentially as described (19); the exact experimental protocol is given 
in the figure legends. Note that although  the phagocytosis assay 
does not discriminate internalized particles from bound particles, 
most particles associated with cells have been internalized  (19). 
Results 
Phagocytic Stimuli Allow K b Presentation of OVA by Thio- 
M~  Weak but reproducible presentation of soluble OVA 
by class  I  K b molecules  of MO  has  been  reported  (13). 
Phagocytosis of particles containing covalently coupled or ad- 
sorbed OVA (OVA beads) greatly augments the efficiency of 
such  presentation  (16-18),  an  effect ascribed  to  enhanced 
delivery of antigen to the endosomal-phagosomal pathway. 
To examine whether augmented antigen delivery to the APC 
fully accounted for the superiority of OVA beads compared 
to soluble OVA or whether phagocytosis might  affect the 
qualitative nature of exogenous antigen handling,  we com- 
pared presentation  by the  thio-MO  of OVA directly con- 
jugated to beads (OVA beads) and of free soluble OVA given 
concomitantly with control beads (OVA  +  BSA beads). 
Surprisingly,  we  detected  little  stimulation  of  a  K b- 
restricted T cell hybridoma, B3Z, after OVA bead uptake by 
H-2  b thio-MO (Fig.  1 A). This was true even though OVA- 
beads were extremely efficient at delivering antigen for pre- 
sentation  by the  same  thio-MO  to  I-Ab-restricted  T  hy- 
bridoma ceUs (Fig. 1 B). The lack of presentation using OVA 
beads and thio-MO  was not caused by chemical modifica- 
tion of the OVA epitope during covalent coupling because 
the same OVA beads led to stimulation of B3Z after uptake 
by non-MO APC (see below). Soluble OVA coadministered 
with BSA beads, however, was presented on K b about 100- 
fold more efficiently than OVA alone (Fig. 1 A). BSA beads 
either did not affect I-A  b presentation of OVA (Fig.  1 B) or 
had a detrimental effect at high particle concentrations (Fig. 
1 D  and data not shown).  This suggested that  the simul- 
taneous exposure of thio-MO to soluble OVA and BSA beads 
did not increase uptake into  at least those portions  of the 
endocytic pathway associated with class II presentation, and 
raised the possibility that the BSA beads affected soluble OVA 
presentation by class I via a qualitative change in the han- 
dling of this protein by the MO. In agreement with this hy- 
pothesis, phagocytosis of beads did not increase the pinocytic 
accumulation of FITC-OVA or lucifer yellow by thio-PEC 
(Fig.  1 E).  The effect of feeding BSA beads together with 
soluble OVA on class I presentation depended on both OVA 
concentration (Fig. 1 A) and on the number of particles ad- 
ministered  (Fig.  1 C).  Similar results were obtained using 
OVA  +  mock-conjugated beads lacking associated protein 
instead of BSA beads (data not shown and see below). BSA- 
beads did not stimulate either hybridoma in the absence of 
OVA (Fig.  1, A  and B). Enhanced presentation  of OVA in 
the presence of beads did not result from upregulation of K b 
or  to  an  increased  proportion  of "empty"  K b molecules 
receptive to exogenous peptide because exposure to BSA beads 
did not affect the dose-response curve for presentation of the 
OVA peptide SIINFEKL (Fig. 2 A) or the response to a fixed 
concentration of the same peptide (Fig. 2 B). Effective pre- 
sentation required relatively simultaneous exposure to beads 
and OVA; even a 30-min delay in antigen addition after bead 
exposure (together with cytochalasin to block further phago- 
cytosis) resulted in little or no stimulation of B3Z (data not 
shown). 
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Figure  1.  Presentation of oval- 
bumin to T  cell  hybridomas  by 
thio-MO.  (A)  Presentation  of 
particulate  and  soluble  OVA to 
B3Z (Kb restricted). (B) Response 
of BO-97.11  (I-Ab-restricted)  to 
the same antigens.  (C) Presenta- 
tion of soluble OVA to B3Z is de- 
pendent on the dose of BSA beads. 
(D) BSA  beads do not  enhance 
presentation  of soluble  OVA to 
BO-97.11.  ThioglycoUate~elicited 
PEC were plated at 5  x  104 per 
well in 96-well plates. After  4 h 
incubation at 37~  nonadherent 
cells were washed off, and the in- 
dicated concentrations  of soluble  or particulate antigens  were added to- 
gether  with B3Z or BO-97.11  T  bybridoma cells (5  x  104 per well) in 
200/~1 complete medium containing 0.25/~M indomethacin.  OVA +  BSA 
beads wells received the indicated concentration  of OVA  +  1.25  x  10  7 
beads per well in A  and B, and the indicated  number of beads per well 
+  10 mg/ml OVA in C and D. The concentrations  of protein in OVA 
beads and BSA beads added in A  and B were calculated from the amount 
bound to beads (see Materials and Methods),  and the top concentration 
of each antigen corresponded to 1.25  x  104 beads per well. Supernatants 
from wells were assayed for  IL-2 content  after 26  h by [3H]thymidine 
incorporation  into CTLb2 indicator  cells.  All the data come from the 
same experiment.  -O-,  BSA beads; ~,  soluble OVA  +  BSA beads; 
---O-, OVA beads; ---A-, soluble OVA. (E) Uptake of soluble OVA is not 
affected by phagocytosis  of BSA beads.  3.5  x  104 thio-PEC were in- 
cubated for 2 h with 0.2 mg/ml of FITC-OVA in the presence or absence 
of BSA beads. Cells were washed and analyzed for FITC fluorescence using 
propidium iodide and live gating to exclude  dead cells. Several doses  of 
BSA beads were tested (only three representative ones are shown): curves 
for 0 (-  beads), 9.3  x  104 (+  beads), or intermediate doses of beads (not 
shown) were superimposable,  indicating that phagocytosis  had no effect 
on pinocytic accumulation of FITC-OVA. At higher doses, the signal from 
the soluble tracer was decreased (shown for 8.3  x  107 [hi beads]). Equiva- 
lent results  were obtained  with lucifer yellow (not shown). 
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Figure  2.  Beads do not affect the presentation of peptide by thio-MO. 
(A) Dose response to SIINFEKL presented by MO with or without 1.25 
x  10  ? BSA beads per well. (B) Effect of bead concentration  on presenta- 
tion of 2/~M of SIINFEKL peptide.  Thio-PEC (5  x  104 per well) were 
cultured with the indicated concentrations  of SIINFEKL and BSA beads. 
After 24 h, adherent cells were washed thoroughly with RPMI 1640 and 
B3Z (5  x  104 per well) were added in 200 #1 complete medium and in- 
cubated for a further 24 h. IF2 was measured as indicated in Fig.  1. BSA 
beads promoted presentation of soluble OVA in the same experiment  (not 
shown). 
Mechanism of Antigen-Processing of Soluble OVA  +  Beads. 
Light paraformaldehyde  fixation of APC results in a marked 
enhancement of the ability of surface class I molecules to bind 
antigenic peptides (30) and allows a 100-1,000-fold increase 
in the stimulatory activity of offered SIINFEKL (see below). 
This provided a sensitive  test for the extracellular  generation 
of class I-binding peptides from soluble OVA, and was used 
as a control to be sure that the effects being observed involved 
an intracellular  processing step. All OVA preparations  used 
in these experiments were first screened by this assay to en- 
sure that they did not give rise to such extracellular  class I 
presentation.  Only occasional batches of OVA, with no corre- 
lation to nominal grade,  passed this stringent test (Fig. 3). 
Interestingly,  when OVA that did not show activity with 
fixed Me  was tested with live Me  in the absence of beads, 
this material  was unable to reproducibly  stimulate B3Z to 
produce  IL-2  (data  not  shown).  We were thus  unable  to 
confirm the existence of a pathway for class  I presentation 
of soluble exogenous antigen in Me  that had not been ex- 
posed to phagocytic stimuli (8, 13), under conditions in which 
the possibility of extracellular  processing was rigorously ex- 
cluded. 
Fixed Me  also  did not present soluble OVA to B3Z in 
the presence of BSA beads,  making it very unlikely that the 
beads  carried  proteases  capable  of generating  functionally 
significant levels  of OVA peptides extracellularly  (Fig. 4 A 
and data not shown). To determine whether presentation in 
the presence  of beads  involved regurgitation  of OVA pep- 
tides generated endocytically  (15, 17), live MHC-incompatible 
MO were mixed with fixed Kb-expressing MO and were ex- 
posed to BSA beads and OVA. This combination was ineffec- 
tive in stimulating B3Z cells; only when Kb-expressing  MO 
were pulsed live were they capable of stimulating IL-2 produc- 
tion by B3Z (Fig.  4 A), despite the bias  towards detection 
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presence of beads was dissected further by analyzing its sus- 
ceptibility  to inhibition by different drugs (Fig.  5). Attach- 
ment of particles to MO cell surface receptors was not suf- 
ficient to permit access to the MHC class I processing pathway 
because cytochalasin D  (CCD),  an inhibitor of phagocytosis, 
prevented presentation (Fig. 5 A).  Presentation was also de- 
pendent on newly synthesized proteins because it was blocked 
by cycloheximide,  suggesting  that  OVA peptides  were not 
being generated  in phagosomal  compartments,  binding to 
K b internalized  from  the plasma membrane,  and recycling 
back to the cell surface (Fig. 5 A).  Consistent with this ob- 
servation,  presentation was also inhibited by brefddin A (BFA; 
Figure  3.  Several  batches of ovalbumin  allow presentation  by Kb that 
is independent  of cellular processing.  Adherent  thio-MO were  fixed in 
1% paraformaldehyde, quenched with glycine, and washed with complete 
medium. Fixed MO were incubated  for 24 h with B3Z (10  s per well) in 
the presence or absence of 20/~M SIINFEKL or different batches of OVA 
at 10 mg/ml. Activation of B3Z was measured by induction of B-galac- 
tosidase activity (see Materials and Methods),  and the results are expressed 
as units of absorbance at 415 nm. Only two batches of OVA (OVA 3 and 
OVA 9) were not presented by fixed MO; OVA 3 was used in most subse- 
quent experiments.  All preparations  of OVA were purchased from Sigma 
and dissolved in complete medium at a stock concentration of 40 mg/ml 
before use. The nominal grade was as follows: OVA 1, 2, 3, 6, 7, grade 
V; OVA 4,  9,  grade  VI; OVA 5,  8,  grade  VII. 
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of peptide transfer when fixed MO expressing K  b were used 
(Fig. 4 B). These results suggest that presentation resulting 
from exposure to OVA  +  beads does not involve extracel- 
lular processing or peptide regurgitation by MO. 
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Figure  4.  Absence of detectable peptide regurgitation during presen- 
tation in response  to OVA  +  beads. (A) Live MHC-mismatched MO 
(B10.A; H-2') pulsed with OVA  +  beads do not transfer OVA peptide 
to fixed MHC-matched MO (B6; H-2  b) despite  the fact that  (B) fixed 
B6 MO present SIINFEKL 100-1,000x  better than live calls. Thio-PEC 
from B6 or B10.A mice were plated at 5  x  104 per well for 6 h at 37~ 
Nonadherent cells were discarded and adherent  cells were fixed as in Fig. 
3. Live MO (5  x  104 per well) of the other haplotype  were added,  to- 
gether with the indicated concentrations  of SIINFEKL or BSA beads  + 
10 mg/ml OVA. Cultures were incubated for 20 h and were subsequently 
washed and fixed again. B3Z (10  s per well) were added in 200 ~1 medium 
and IL-2 was measured 24 h later as in Fig. 1. ~,  live B6/fixed B10.A; 
-I-,  live B10.A/fixed  B6. 
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Figure  S.  Effect of drugs on presentation  of OVA  +  BSA beads.  (A 
and  B) Thio-PEC (10  s per well)  were plated,  incubated  for 24 h,  and 
nonadherent  cells were discarded.  Adherent  MO were preincubated  for 
60 rain at 37~  with medium alone (No Tx -1-), or medium containing 
0.5/zg/ml BFA --C]-,  10/~g/ml CCD --A-,  10/~g/ml cycloheximide 
(CHX -O--), 20 mM ammonium chloride  (NH4C1 -<>-), 200/~g/ml 
leupeptin --~-, or 100 #M chloroquine (CHQ -I1-). The indicated con- 
centration of OVA  +  1.25  x  107 mock-conjugated  beads (A) or SIIN- 
FEKL (B) was then added in medium containing the respective drug, as 
necessary to maintain  a coustant  drug concentration.  After 4 h incuba- 
tion, adherent  cells were washed  and fixed as described  in Fig.  3.  B3Z 
(6  x  104 per well) were added and Ib2 content of superuatants was mea- 
sured 22 h later.  (C and D) Thio-PEC were plated at 10  s per well with 
the indicated number of 1.5 #m Polybeads  +  10 mg/ml OVA (C) or the 
indicated  concentration  of SIINFEKL (D) in the presence or absence of 
1 /~M gelonin. After 22 h  incubation,  adherent  MO were washed  and 
fixed as in A  and B, and B3Z (10  s per well) were added for 22 h.  IL-2 
content of supernatants  was measured  as in Fig.  1.  The data in A  and 
B and C and D come from the same experiments. -0%  without gelonin; 
--O-, with gelonin.  The data in B are expressed as Ib2 units as calcu- 
lated  from supernatant  dilutions (28) and  do not have error bars. 
845  Reis e Sousa and Germain Fig. 5 A), a drug that prevents egress of proteins from the 
endophsmic  reticulum (ER) and Golgi while allowing plasma 
membrane recycling (31). Neither drug affected presentation 
of the SIINFEKL peptide, which is dependent on preexisting 
plasma membrane K b rather than newly synthesized mole- 
cules (Fig. 5 B). It is noteworthy that the ability of BFA to 
inhibit presentation of OVA + beads is in disagreement with 
the results reported by Harding and Song for OVA directly 
conjugated to beads (17), but that it is in agreement with 
a recent report by Kovacsovics-Bankowski  and Rock (18) using 
the same antigen. Also in agreement with the latter report, 
chloroquine did not affect presentation by MO exposed to 
OVA + beads (Fig. 5 A). However, the interpretation of this 
result is complicated by the fact that chloroquine also promoted 
class I presentation of soluble OVA in the absence of phago- 
cytic stimuli (data not shown). Other endosomal degrada- 
tion inhibitors such as ammonium chloride or leupeptin did 
inhibit K  b presentation of OVA by MO after  exposure to 
OVA  +  beads  (Fig.  5 A), but not peptide (Fig.  5 B), al- 
though it is not dear if this was caused by inhibition of pro- 
teolysis or alterations in endosomal traffic. 
These results were consistent with a model in which phago- 
cytosis of beads allowed delivery of intact or partiaUy proteo- 
lyzed OVA into the cytosol for further processing as a con- 
ventional endogenous antigen and import into the ER in the 
form of peptides via transporter associated with antigen pro- 
cessing (TAP). An alternative explanation was that peptides 
were generated in the endo/phagosomal cisternae and bound 
to newly synthesized K b in a TAP-independent manner as 
the dams  I traffacked  through the post-ER portion of the secre- 
tory pathway. To differentiate between these models, we ex- 
amined  the  susceptibility  of  presentation  to  gelonin,  a 
membrane-impermeant protein synthesis inhibitor that is usu- 
ally nontoxic to living cells because it has no access to the 
cytosol (13, 18, 32). Gelonin inhibited presentation of OVA 
offered to MO in the presence  of beads  (Fig.  5 C) while 
leaving intact the ability of the MO to present peptide (Fig. 
5 D). This result suggests that phagocytosis of beads allows 
access of relatively intact exogenous proteins to the cytosol, 
where they can be acted upon by the conventional MHC dams 
I processing pathway. 
Phagocytosis Allows K b Presentation of OVA  by Nonprofes- 
sional Phagocytes.  Because presentation by K  b of peptides 
derived from soluble OVA appeared to result from a qualita- 
tive change in antigen handling induced by phagocytosis rather 
than simply from increased delivery of antigen, we examined 
whether phagocytic stimuli could induce other APC to present 
OVA to B32. Langerhans cell-depleted EC containing phago- 
cytic keratinocytes (19) were pulsed with OVA beads or OVA 
+  beads and assayed for activation of B3Z. Like thio-MQ, 
EC stimulated B3Z after exposure to OVA + beads, but un- 
like the former APC, EC also stimulated the byhridoma after 
exposure to OVA beads (Fig. 6). Similar results were obtained 
with the fibroblast  line 1-3 (K  b) and, after IFN-ot,fl treat- 
ment to induce TAP expression, with the embryonic cell line 
E3 K b, both of which were capable of phagocytosing parti- 
cles (data  not shown). Neither phagocytic stimulus, how- 
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Figure 6.  Nonprofessional phagocytes can also  present OVA on K b 
upon phagocytic stimulation. Epidermal cells depleted of Langerhans cells 
were cultured at 3.5  x  10  s per well with the indicated concentrations 
of antigen. After 24 h, B3Z (5  x  104 per well)  were added,  incubated 
for 24 h, and IL-2 was measu~d as in Fig.  1. Concentration of protein 
added as OVA beads was calculated  as in Fig.  1; the top concentration 
shown corresponded to 1.1  x  106 OVA beads per well.  Higher concen- 
trations of beads inhibited the response (not shown). Cultures incubated 
with OVA  +  BSA beads received 1.25  x  107 BSA beads per well in ad- 
dition to the indicated concentration of OVA. 
ever, promoted presentation of OVA to B3Z by LB 27.4, a 
nonphagocytic B cell hybridoma (33),  supporting the no- 
tion that presentation is related to the ability to internalize 
particles  (data  not shown). 
Different Phagocytic Stimuli Promote K b Presentation of OVA. 
We next tested the ability of different phagocytic stimuli to 
induce presentation of soluble OVA to B3Z by thio-MO. 
Phagocytosis of 1-2-/~m latex particles  promoted presenta- 
tion, although 1-#m particles appeared to be somewhat less 
effacient than larger beads (Fig. 7 A). Dynabeads  TM (4.5-#m) 
were as efficient as BSA beads at promoting presentation (Fig. 
7 A). All of these particles inhibited presentation when used 
in amounts greater than 1-50  x  107 particles per well, pos- 
sibly caused by steric interference with the interaction be- 
tween APC and B3Z (data not shown). In contrast to latex 
or magnetic particles, degradable particles such as zymosan 
(yeast cell walls, 2-4-/~m diameter) or formaldehyde-fixed bac- 
teria (Staphylococcus aureus, Escherichia col  0 did not have any 
effect at concentrations at which latex and magnetic beads 
gave high dose inhibition (Fig.  7 A  and data not shown). 
Zymosan and S. aureus, however, were able to stimulate K b 
presentation of OVA by MO when 100-fold more particles 
were used than with nondegradable particles (Fig. 7 B; other 
particles not tested at these doses). The relative inef~dency 
of the biological particles in promoting presentation of coad- 
ministered OVA  was  not  caused  by competition for  K b 
binding by peptides derived from these particles because 
cofeeding zymosan did not alter the dose response to OVA 
+  latex beads (data not shown). 
Phagocytic Stimuli Induce Class I Presentation by Only a Subset 
of  APC Taking up Both Particles  and Ana'gen.  Although phago- 
cytosis of particles was dearly able to induce class I presenta- 
tion of OVA to B3Z, the total amount of IL-2 produced at 
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Figure 7.  Different phagocytic particles stimulate class I presentation 
by thio-MO with varying efl~ciencies. (,4) Thio-PEC were plated with 
the indicated number of particles per wen  +  10 mg/ml OVA, cultured 
for 22 h, and washed and fixed as in Fig. 3. B3Z were added at 5  x  104 
per well and Ib2 in supernatants was measured 24 h later by proliferation 
of CTLb2 indicator cells as in Fig.  1. (B) Thio-PEC were cultumJ for 
2 d, nonadherent cells were discarded, and the indicated number of zymosan 
or S. aureus particles  +  5 mg/ml OVA were added to each well before 
overnight incubation. Adherent MO were washed and fixed and B3Z were 
added for 24 h. Ib2 in supernatants was measured by ELISA and the means 
of triplicate cultures were converted to IL-2 U/m1 by comparison to a stan- 
dard curve.  Note that the scale of the x  axis is the same in both A  and 
B to facilitate comparison. The data in A  and B come from separate ex- 
periments. -O-,  1.0/~m latex; -~-,  1.5 #m latex; -A-, 2.0/zm latex; 
-I-,  BSA beads; ~,  DynabeadsTM; --A--, S. aureus; -g-,  zymosan. 
optimal beads numbers and maximal available concentrations 
of soluble OVA was much lower than that which could be 
obtained using SIINFEKL-pulsed APC in the same experi- 
ment. For example, supernatants from stimulation assays using 
APC exposed to OVA  +  beads could seldom induce half- 
maximal proliferation of CTLL-2 indicator cells at a 1:4 di- 
lution, whereas supernatants from peptide-stimulated cells 
did so at  1:30 dilution or greater (see Fig.  5, A  and B). 
Peptide reconstruction experiments demonstrated that the 
response obtained with OVA  +  beads could be replicated 
using APC uniformly pulsed with low concentrations of SIIN- 
FEKL or by diluting APC pulsed with high concentrations 
ofpeptide into unpulsed APC (data not shown). To differen- 
tiate between these models (a low average density of peptide- 
K b on all cells versus a few cells with substantial levels and 
many cells with essentially no complexes), we used lysis by 
CTL  specific  for  OVA  +  K b to  determine the  absolute 
number of thio-MO that presented immunologically rele- 
vant numbers of OVA peptides in association with class I 
after exposure to OVA +  BSA beads. These CTL responded 
to offered SIIN~KL at peptide concentrations 100 times lower 
than necessary to obtain a measurable response from B3Z (data 
not shown). In three consecutive experiments, at all tested 
E/T ratios, the maximal amount of specific killing of PEC 
pulsed with OVA +  BSA beads was 10-15% above the back- 
ground obtained with OVA alone, although 80-100% of PEC 
pulsed with SIINFEKL peptide were capable of being lysed 
by the same CTL population (Fig.  8 A). These results sug- 
gested that after pulsing with OVA  +  BSA-beads,  only a 
fraction of PEC were able to present OVA peptides in associ- 
100 )B1.3 (Kb) 
;  -  ~  8 
E/l" ratio 
Figure  8.  Anti-OVA CTL kill only a fraction of APC pulsed with OVA 
+  beads. 3  x  106 thio-PEC (,4) or 5  x  104 1-3 (K  b) (B) were incubated 
in sterile  polyproFylene  tubes in medium alone (No  Tx) or in medium 
containing OVA  _+ BSA beads or 1 #M SIINFEKL. OVA concentrations 
were 1 mg/ml in A  and 5 mg/ml in B, and BSA beads were added at 
1.25  x  10  s per tube in A  or 2.5  x  10  s per tube in B. After overnight 
culture, cells were washed, labeled with stCr, and used as targets for a 
CTL line against SIINFEKL  +  K b in a standard 4-h chromium release 
assay at different E/T ratios.  The data in A  and B come from separate 
experiments.  -O-,  no Tx; --0-, OVA; -A-, OVA  +  BSA beads; -i-, 
SIINFEKL. 
ation with K b at levels adequate for stimulation of highly 
sensitive CTL. 
Class I Presentation Induced by Phagocytic Stimuli may be a 
Stochastic Event.  Thio-PEC  contain activated and resting 
MO in addition to inflammatory cells. Conceivably, one of 
these cell types might account for the subpopulation of PEC 
that presented OVA-derived peptides in association with class 
I after exposure to soluble antigen plus beads, perhaps by ex- 
pressing higher levels of K b, or because of quantitative differ- 
ences in the amount of OVA or particles internalized. Flow 
cytometric analysis, however, revealed that thio-PEC had a 
unimodal distribution of surface K b expression (Fig.  9 A), 
FITC-OVA and lucifer yellow uptake (Fig.  1 E), and uptake 
of fluorescent latex beads (Fig.  9 B). 
A 
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Figure  9.  FACS  |  analysis of thio-PEC. (A) Uniform expression of K b 
by thio-PEC.  Fixed  cells were stained with FITC-conjugated a-K  b or 
FITC-conjugated mouse IgG2a as a negative control (B) Uniform uptake 
of fluorescent htex beads by thio-PEC. 5  x  106 thio-PEC were incubated 
overnight with 2.5  x  10  s fluorescent latex beads (1.5 #m), and propidium 
iodide-negative cells were analyzed  for association  with particles. 
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tion for the existence of only a subset of thio-PEC with the 
ability to present exogenous antigen-derived peptides via dass 
I, but it could not address the possibility that the PEC con- 
tained a subset of cells with a distinct intracellular pathway 
for delivery of phagosomal antigens into the dass I processing 
pathway. To explore this issue, we turned to our observation 
that non-MO were also capable of presenting OVA peptides 
via K b after exposure to OVA  +  beads.  Such cloned cell 
lines should not show marked heterogeneity in the activity 
of any such putative transport pathway. When 1-3 (K  b) cells 
pulsed with OVA +  particles were tested for killing by CTL, 
however, a low level of specific lysis was again observed (Fig. 
8 B) despite the fact that more than 90% of 1-3 (K  b) cells 
were associated with particles (data not shown). Thus, even 
a clonal cell population showing extensive bead and antigen 
uptake generates only a few cells with substantial OVA peptide- 
K b display on the cell surface. 
Discussion 
The hypothesis (34) that MHC class I molecules present 
peptides derived from cytosolic antigens ("endogenous an- 
tigens"), whereas MHC class II molecules present peptides 
derived from antigens in the endocytic pathway ("exogenous 
antigens"), has become the generally accepted paradigm for 
antigen processing (1). The segregation between the two an- 
tigen presentation pathways, however, is not absolute and there 
are examples of MHC class II presentation of endogenously 
synthesized, cytosolic antigens (35), as well as several instances 
of class  I responses to exogenous antigens (36).  Although 
some examples of this type have been claimed to represent 
binding to class I or II in sites other than the ER or endo- 
somes,  respectively,  most  appear  to  represent  unexpected 
routing of an exogenous antigen into the cytosol or an en- 
dogenous antigen to the endocytic pathway, followed by MHC 
class I or class II molecule loading in their preferred com- 
partments (1). It is possible that these exceptions represent 
the activity of specialized APC possessing different mecha- 
nisms for translocating protein antigens or their fragments. 
In this respect, MO have been suggested to process a unique 
pathway for presentation of peptides derived from exogenous 
soluble antigens in association with MHC class I molecules 
(13,  14).  Because the discovery of novel protein or peptide 
transport mechanisms involved in antigen presentation is of 
substantial importance to both immunology and cell biology, 
we undertook a reexamination of soluble antigen presenta- 
tion by MHC  class  I molecules of M(D. 
Unlike previous studies using the same protein antigen 
(OVA) and MHC class I presentation element (K  b) (8, 13), 
presentation by MO of peptides derived from soluble OVA 
was not observed consistently. Because a different assay T 
cell (B3Z) was used in our study compared to that used by 
Rock and colleagues, we cannot rule out the possibility that 
their assay system was more sensitive, and detected presenta- 
tion at a level that we could not. We have noticed, however, 
that many batches of OVA purchased commercially (seven 
of nine tested, Fig. 3) allow presentation by fixed M(D after 
pulsing in serum-containing medium, possibility as a result 
of extracellular processing by serum pmteases (37, 38). Parafor- 
maldebyde fixed MO are a very sensitive indicator of extracel- 
lular proteolysis, as they present peptide 100-1,000x  better 
than live cells (Fig. 4 B  and reference 30) and better than 
other fixed cell types with higher levels of K b such as 1-3 
(K  b) (Reis e Sousa, C., and R. N. Germain, unpublished ob- 
servations). When we used ultra-"clean" preparations of OVA 
that could not be presented by fixed MO, we no longer were 
able to reproducibly obtain presentation of soluble antigen 
to B3Z by live M(D without addition of beads, although weak 
presentation of unscreened antigen was occasionally seen (e.g., 
Figs. 1 A and 6). Thus, it does not appear that M{D are con- 
stitutively capable of efficient processing and presentation of 
free soluble protein antigens via the class I pathway, although 
it can readily be shown by use of labeled antigen or assays 
of MHC class  II presentation that these cells take up sub- 
stantial amounts of protein into the endocytic pathway. 
Class I responses to exogenous antigens in vivo, however, 
appears most often to involve particulate rather than soluble 
antigens (whole cells or cell debris in cross-priming [2-4, 
6-12], bacteria and protozoa during infections [9, 10]). There- 
fore, much attention has been focused on recent reports sug- 
gesting that phagocytosis markedly increases the efficiency 
of processing of exogenous antigens for MHC class I presen- 
tation by M{D (15-18). It is possible that inefficient delivery 
of exogenous antigens to the class I pathway can be compen- 
sated for by phagocytic uptake which increases the effective 
delivery of antigen to the cell, compared to fluid phase up- 
take (16,  17).  Surface Ig uptake of antigen is known to in- 
crease class II antigen presentation efficiency by three to four 
orders of magnitude (39), and this is consistent with the data 
of Barnaba et al., who found that antigen-specific, but not 
unspecific B cells, could present hepatitis surface antigen via 
class I (7).  In accord with this, class I presentation was not 
observed by either Rock or ourselves using antigen-unspecific 
B cells and soluble antigen. Alternatively, the process of ac- 
tive phagocytosis could stimulate a cell to turn on a specific 
protein/peptide transport pathway that would deliver antigen 
into the class  I pathway. 
To distinguish between these possibilities, it was neces- 
sary to dissociate antigen uptake from particle delivery, to 
examine several cell types in the presence and absence of phago- 
cytic stimuli, and to vary these stimuli. When these experi- 
ments were performed, we found that several types of inert 
unconjugated particles could promote class I presentation of 
soluble OVA via class I. This gain in presentation activity 
could not be accounted for by increased antigen uptake be- 
cause the accumulation of soluble tracers by cells pulsed with 
particles was not increased (Fig. 1 E) and OVA directly con- 
jugated to particles was less efficient at promoting presenta- 
tion to  B3Z by thio-MO  despite being more efficient at 
delivering antigen for class  II presentation (Fig.  1).  These 
results argue strongly in favor of a qualitative rather than 
quantitative effect of phagocytosis on class I presentation of 
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tration of particles and antigen (Reis e Sousa, C., and R. N. 
Germain, unpublished results), implying either a physical basis 
to the activity rather than the induction of a novel transport 
pathway, or the exclusive localization of any putative trans- 
port system to the phagosomes formed at the time of bead 
exposure. 
The inability of thio-MO to show effective class I presen- 
tation of OVA directly conjugated to beads is in contrast to 
previous results (16-18) also using inert particles conjugated 
to comparable amounts of antigen. This did not result from 
a failure to enhance ddivery of OVA to the thio-MO because 
we observed greatly augmented class II presentation of an 
OVA-derived peptide by the same cells. Nor did it result from 
a chemical inactivation of the SIINFEKL determinant within 
the conjugated OVA, since the same OVA beads were able 
to sensitize non-MO for class I presentation to the same assay 
hybridoma. We are thus unable to explain the difference be- 
tween our studies and those of others, other than to suggest, 
based on the detectable activity of the conjugates in non-MO 
environments, that there may have been more extensive degra- 
dation of the OVA by the MO populations, leading to less 
presentation than with soluble OVA  +  beads. This reduced 
level of presentation may nevertheless have been sufficient to 
trigger the particular hybridomas used in the other studies 
(16-18). 
Despite this clear difference in the behavior of OVA beads 
between the two studies,  the mechanism of presentation of 
OVA  +  beads  had the characteristics  of the endogenous 
pathway for dass I processing (Figs. 4 and 5), as was reported 
by Rock and colleagues for presentation of OVA directly con- 
jugated to beads (16, 18), and in contrast to the mechanism 
of peptide regurgitation invoked by Harding et al. (15, 17). 
This capacity was not unique to MO, however, as previously 
suggested (16-18). Rather, several different cell types capable 
of phagocytosis (keratinocytes,  embryonic cell lines,  fibro- 
blasts),  but not the one nonphagocytic cell we tested (a B 
hybridoma), were able to present OVA peptides in associa- 
tion with K b when coexposed to phagocytic stimuli, but 
not soluble OVA alone. Several particle types were effective 
in promoting class I presentation of OVA. These findings, 
together with the absence of a quantitative explanation for 
the effect of bead exposure on class I presentation of soluble 
OVA, encouraged us to further examine whether phagocy- 
tosis induced the activity of a novel pathway for importing 
endosomal antigens into the cytosol, analogous in reverse to 
the import of cytosolic antigens for degradation in lysosomes 
(40). Such a pathway from endosomes to cytosol has not been 
described,  although isolated lysosomes have been reported 
to release  peptides in vitro, apparently in the absence of damage 
to lysosomal membranes (41). A powerful biological argu- 
ment for the existence of such a pathway is that tying MHC 
class I processing of exogenous antigens to phagocytosis would 
allow presentation of antigens derived from endosomal para- 
sites while excluding presentation of soluble macromolecules 
taken up as part of a cell's normal pinocytic traffic; this would 
make it possible to discriminate between cells infected with 
endosomal parasites and those that have taken up parasite pro- 
teins but are not infected. 
It was thus surprising to note that the magnitude of the 
response to OVA +  particles was at most only a few percent 
of that achieved using peptide antigen, despite a unimodal 
expression of K b, the very efficient uptake of beads by vir- 
tually all MO, and the ready detection of cointernalized pro- 
tein by the same cells. If phagocytosis could activate a phago- 
some-to-cytosol protein/peptide delivery system, presentation 
under these conditions should be much more effective. The 
inefficiency of presentation raises questions about the suita- 
bility of this approach for the development of vaccines in- 
tended to elicit strong CTL responses (16-18),  particularly 
in view of alternative (possibly more effective) strategies, in- 
cluding viral vectors or liposomes. Nonetheless, because thio- 
PEC are heterogeneous, other factors that are the property 
of a particular stage of activation or subpopulation of ceils 
(for example, levels of TAP-1 and TAP-2 expression) might 
limit the function of this pathway. Experiments using CTL 
did suggest that the low presentation resulted from having 
only a small subpopulation of cells presenting OVA via class 
I, rather than the inefficient presentation of antigen by all 
the cells in the MO population. We have so far been unable, 
though, to find substantial differences between thio-PEC be- 
fore or after treatment with IFN-3', or between thio-PEC 
and bone marrow-derived MO, in the presentation of OVA 
offered in the presence of beads (not shown). Moreover, analysis 
of CTL killing of a clonal, nonprofessional phagocytic APC 
[1-3 (Kb)],  also revealed a similar low level of sensitization 
by OVA  +  beads that again resulted in CTL lysis of only 
a small fraction of all phagocytically active cells in the popu- 
lation (Fig.  8 B). 
These results are difficult to reconcile with the hypothesis 
that phagocytosis per se activates a novel antigen-processing 
pathway that has evolved to respond to infections by endosomal 
parasites. It clearly remains possible that the immune system 
has developed a specific mechanism for sensing (live) intra- 
cellular pathogens that induces an efficient pathway for delivery 
of endosomal/phagosomal antigens into the class I pathway, 
a mechanism for which we have not provided the proper in- 
ductive stimulus. A  simpler explanation, however,  is that 
among APC that have taken up large numbers of particles, 
escape of antigen from some vesicles into the cytosol occurs 
in a few ceils, with consequent access to the endogenous 
pathway for MHC class I presentation, in a manner similar 
to that achieved by osmotic lysis of pinosomes (37). We term 
this the "indigestion" model because it involves particle over- 
loading of the phagosomal compartment. This "indigestion" 
model is consistent with the observation that larger,  non- 
degradable  particles  are much more efficient than smaller, 
degradable ones at promoting class I presentation in MO 
(Fig.  7). 
Antigen escape might be affected by whether a particle 
aggregate enters a single phagosome or by membrane com- 
position and, consequently, by the stage of the cell cycle or 
the stage of differentiation of the cell. It could involve in- 
complete fusion events between two phagosomal vesicles, al- 
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disruption of the phagosomal membrane. The latter mecha- 
nism is used by Listeria and Trypanosoma organisms to establish 
intracdlular infection through secretion of specific hemolysins 
(9,  10).  Cytosolic  entry,  however,  can  be  observed with 
microorganisms  not known to possess hemolysins, such as 
some strains  of Mycobacteria, which are normally confined 
to the endosomal compartment  (42,  43).  Cytosolic escape 
of Mycobacteria tuberculosis occurs in alveolar MQ from naive 
rabbits but not in MO from rabbits immunized with M. boris 
bacillus Calmette-Gutrin,  demonstrating  that escape is de- 
pendent,  at least in part,  on properties of the infected cell 
(43). Thus, "indigestion" after uptake of inert particles might 
actually mimic what happens during active replication of an 
organism  in the phagosomal  compartment.  Disruption  of 
membrane integrity (an "ulcer") would develop if the phago- 
cyte could not control parasite replication, or if the parasite 
arrested lysosomal degradation by preventing fusion of the 
phagosomal vacuole with lysosomes or by neutralizing pha- 
gosomal pH (9,  10).  Such a mechanism would specifically 
mark for CTL lysis only those cells in which parasite replica- 
tion went unchecked. Normal scavenging activity in the ab- 
sence of infection should not give "indigestion" and, hence, 
should not sensitize MO for CTL killing.  A  critical event 
in determining escape could therefore be the inability to con- 
dense phagosomes and recycle membrane to the cell surface 
(44).  Further  studies are dearly warranted  to determine if 
"indigestion" during infection by intracellular parasites con- 
tributes to the recruitment  of CD8 effectors to the site of 
infection. 
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